Table: begin end state 1 23 signal peptide 24 31 non-cytoplasmic 32 52 transmembrane 53 88 cytoplasmic 89 111 transmembrane 112 116 non-cytoplasmic 117 139 transmembrane 140 159 cytoplasmic 160 183 transmembrane 184 190 non-cytoplasmic 191 209 transmembrane 210 220 cytoplasmic 221 239 transmembrane 240 257 non-cytoplasmic 258 277 transmembrane 278 284 cytoplasmic 285 305 transmembrane 306 324 non-cytoplasmic 325 345 transmembrane 346 364 cytoplasmic 365 390 transmembrane 391 463 non-cytoplasmic 464 484 transmembrane 485 508 cytoplasmic 509 528 transmembrane 529 540 non-cytoplasmic 541 565 transmembrane 566 571 cytoplasmic 572 592 transmembrane 593 640 non-cytoplasmic 641 662 transmembrane 663 689 cytoplasmic
Input: >HSERO_RS09795 FitnessBrowser__HerbieS:HSERO_RS09795 MNRIVSRLGWLALALAGAGACAYVALQRGESINAVWLVVAAVCVYLIAYRFYSKFIADRV LGLDGGRMTPAYKFNDGLDYVPTNKYVLFGHHFAAIAGAGPLVGPVLAAQMGYLPGMLWI LAGVVFAGAVQDFMVLFISTRRDGRSLGDLIKSELGQVPGVIALFGAFMIMVIILAVLAL IVVKALAESPWGSFTVAATIPIALFMGVYSRYIRPGRIGEVSWIGFVLLMLAIVGGQYVQ EHPALGQMFTFDGKQLTWMLIGYGFVASVLPVWLLLAPRDYLSTFLKIGTILALALGIVF IAPHLKMHAVTRFIDGSGPVWSGSLFPFLFITIACGAVSGFHALISSGTTPKLLENEKHA RFIGYGAMLMESFVAIMALIAASCIEPGIYFAMNSPAALIGTTPENVAQVISQWGFHITP EMLTHTAQAVGEHTIISRAGGAPTLAVGMAQILSGVTGEAMMAFWYHFAILFEALFILTA VDAGTRAGRFMLQDLLGAFIPPMKRTDSWVASLIATGLCVAGWGYFLYQGVVDPLGGINT LWPLFGISNQMLAGIALILATCVLFKMKRDRFAWVTVLPTAWLLACTLTAGWQKVFDANP RVGFLAHASKYQAALDEGKLLAPAKSIEQMRQVIFNDYVDAGLAAMFMLVVISVLVFGIR TVLKARSAHQPSVKEAPYETLPASALAQQ
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server